Medical devices, healthcare technology and the business of care
FDA RECALL RECORD · Z-2654-2026

MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555 Recall

MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555 Catalog Number: SAM2461 UDI code: N/A Engineering Sample/Not for Human Use

FDA recall Class II

Ongoing

FDA lists this Class II recall for MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555. Review the affected identifiers, reported reason and manufacturer instructions below.

Recall at a glance

Recall number
Z-2654-2026
Recall classification
Class II
Enforcement status
Ongoing
Initiation date
Jun 4, 2026
FDA report date
Jul 8, 2026
Quantity in commerce
50 devices
Distribution
See key details
FDA cause
Under Investigation by firm

What is being recalled?

MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555 Catalog Number: SAM2461 UDI code: N/A Engineering Sample/Not for Human Use

Affected model & UDI checker

Search the exact identifiers published for Z-2654-2026.

The lookup covers structured identifiers listed on this page. A full UDI may also contain lot or serial information; a GTIN match alone does not check those conditions.

Affected products

Model / catalog numberProductLot scope reportedUDI / GTIN
SAM2461MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555Check source noticeNot specified
DYNDTN0555MEDLINE 111 GRAVITY SET W/3 Needle Free Y-Sites REF DYNDTN0555Check source noticeNot specified
FDA code information

Catalog Number: SAM2461 REF: DYNDTN0555 UDI code: N/A Lot Number: 25X445

View the original FDA recall notice

Why was this product recalled?

Due to engineering sample labeled "Not for Human Use" being inadvertently shipped it the U.S. market.

What actions did BD SWITZERLAND SARL take?

On 06/04/2026, the firm email an "URGENT: MEDICAL DEVICE CORRECTION" Letter informing customers that BD is recalling Engineering Samples labelled Not for Human Use listed above that were inadvertently shipped to the U.S. market. Customers are instructed to: 1. Cease use and destroy any unused affected product listed in the table above according to your facilities regulations. 2. Circulate this notice to all those who need to be aware within your organization or to any organization where the potentially affected products have been transferred. 3. Complete the attached Customer Response Form and return to the BD contact noted on the form whether or not you have any of the impacted material so that BD may acknowledge your receipt of this notification. For Questions - Phone: 1-844-8BD-LIFE (1-844-823-5433) Say Product Complaints when prompted Mon Fri 8:00am and 5:00pm CT or Email: productcomplaints@bd.com

Read the manufacturer action recorded by FDA

Recall timeline

  1. Recall initiated by firm

  2. FDA notice posted

  3. FDA classification recorded

  4. FDA enforcement report date

Related FDA submissions

No submission number with an exact verified relationship is linked in the retrieved recall notice.

FDA’s notice explicitly links the submission numbers shown here. Read each filing for its own recorded device and scope.

Source and update history

  1. FDA enforcement data

    First stored snapshot of this source.

  2. FDA device-recall notice

    First stored snapshot of this source.

The history starts with the versions held by MedtechLedger. Earlier source changes are not reconstructed. Official dates and recorded status come from FDA; page summaries describe the source information.

Our data sources and methodology